Nan Fajun
Medical School
University of Chinese Academy of Sciences
Shanghai
Language: Chinese, English
Contact
Drug Synthesis Organic Chemistry Pharmaceutical Chemistry Chemical Synthesis Medicinal Chemistry Drug Development Synthetic Methods Chemical Reactions Molecular Design Bioorganic Chemistry
Areas of Focus
  • Drug Synthesis Chemistry
Work Experience
  • 2000-05 to 2016-06 - Shanghai Institute of Materia Medica - Researcher
  • 1997-08 to 2000-05 - Georgetown University Medical Center - Postdoctoral
  • 2014-08-31 to 2016-06-17 - East China Normal University - Adjunct Professor
  • 2011-05-01 to 2016-06-17 - Shanghai Pharmaceutical Association - Director
  • 2005-07-01 to 2016-06-17 - Drug Discovery Today - Advisory Editorial Board
  • 2004-09-01 to 2016-06-17 - Huazhong University of Science and Technology - Adjunct Professor
Academic Background & Achievements
  • 1994-09 to 1997-06 PhD: Shanghai Institute of Organic Chemistry
  • 1991-09 to 1994-06 Master's: Lanzhou University
  • 1987-09 to 1991-06 Bachelor's: Lanzhou University
Publications
  • Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation, 11th Author, 2016
  • Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2), 5th Author, 2016
  • Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy, 11th Author, 2016
  • Discovery and structural optimization of 1-phenyl-3-(1-phenylethyl)urea derivatives as novel inhibitors of CRAC channel, 8th Author, 2015
  • P-Retigabine: An N-Propargyled Retigabine with Improved Brain Distribution and Enhanced Antiepileptic Activity, 10th Author, 2015
  • Disruption of the unfolded protein response (UPR) by lead compound selectively suppresses cancer cell growth, 13th Author, 2015
  • Targeting the gamma-/beta-secretase interaction reduces beta-amyloid generation and ameliorates Alzheimer's disease-related pathogenesis, 11th Author, 2015
  • Potent and Orally Efficacious Bisthiazole-Based HistoneDeacetylase Inhibitors, 7th Author, 2014
  • Design and synthesis of 3,3 '-biscoumarin-based c-Met inhibitors, 7th Author, 2014
  • Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy, 6th Author, 2014
  • Total Synthesis of Aphadilactones A-D, 4th Author, 2014
  • Single-Cell Chemical Proteomics with an Activity-Based Probe: Identification of Low-Copy Membrane Proteins on Primary Neurons, 11th Author, 2014
  • Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors, 8th Author, 2014
  • Discovery of a NegativeAllosteric Modulator of GABA B Receptors, 7th Author, 2014
  • Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation, 11th Author, 2014
  • Small molecule compound induces chromatin de-condensation and facilitates induced pluripotent stem cell generation, 9th Author, 2014
Awards
  • Pudong New Area Science and Technology Progress Award (2015): First Prize
  • First Batch of Leading Talents in Scientific and Technological Innovation of the 'Ten Thousand Talents Program' (2013): National Level
  • National 'New Century Talents Project' (2009): National Level
  • Shanghai Leading Talent Award (2007): Provincial Level
  • Shanghai Science and Education Party Committee System Youth Science and Technology Innovation Talent Award (2006): Provincial Level
  • 8th Wu Jieping Medical Research Award - Paul Janssen Pharmaceutical Research (2004): Second Prize
  • Establishment of National New Drug Screening Center and Research and Application of High-Throughput Screening Technology (2003): Second Prize, National Level
  • Research and Application of Modern New Drug Screening System and High-Throughput Screening Technology (2002): First Prize, Provincial Level
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.